Chrysoli Consulting

Chrysoli Consulting

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Chrysoli Consulting is a specialized boutique consultancy focused exclusively on the market access and commercialization challenges facing biopharmaceutical and medical device companies. Leveraging deep industry expertise and a patient-centric approach, the firm offers strategic guidance in areas such as pricing, reimbursement, HEOR, and stakeholder engagement. While it operates in the Digital Health and AI/ML sectors, its core business model is service-based consulting rather than developing proprietary therapeutic or technology products. The firm is privately held, led by founder Damian M. May, and caters to large, established clients in the life sciences industry.

Digital HealthAI / Machine Learning

Technology Platform

Utilizes data analytics, AI, and machine learning as embedded tools within its consulting services to provide data-driven market access, HEOR, and pricing strategy.

Opportunities

Growing complexity in drug pricing and reimbursement, especially for high-cost specialty therapies, drives sustained demand for expert advisory services.
The integration of real-world data and AI in healthcare commercialization presents an opportunity to offer advanced, data-driven consulting solutions.

Risk Factors

Revenue is vulnerable to client concentration and fluctuations in biopharma outsourcing budgets.
Heavy reliance on the founder's reputation and a competitive landscape with larger consultancies pose significant business and talent retention challenges.

Competitive Landscape

Competes with large global consultancies (e.g., IQVIA, McKinsey) and numerous boutique specialty firms in the market access and HEOR space. Differentiation is based on deep, hands-on industry expertise, a patient-centric focus, and agility as a smaller firm.